{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:08:15Z","timestamp":1793660895266,"version":"4.5.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vaccine discovery against eukaryotic parasites is not trivial as highlighted by the limited number of known vaccines compared to the number of protozoal diseases that need one. Only three of 17 priority diseases have commercial vaccines. Live and attenuated vaccines have proved to be more effective than subunit vaccines but adversely pose more unacceptable risks. One promising approach for subunit vaccines is in silico vaccine discovery, which predicts protein vaccine candidates given thousands of target organism protein sequences. This approach, nonetheless, is an overarching concept with no standardised guidebook on implementation. No known subunit vaccines against protozoan parasites exist as a result of this approach, and consequently none to emulate. The study goal was to combine current in silico discovery knowledge specific to protozoan parasites and develop a workflow representing a state-of-the-art approach. This approach reflectively integrates a parasite\u2019s biology, a host's immune system defences, and importantly, bioinformatics programs needed to predict vaccine candidates. To demonstrate the workflow effectiveness, every <jats:italic>Toxoplasma gondii<\/jats:italic> protein was ranked in its capacity to provide long-term protective immunity. Although testing in animal models is required to validate these predictions, most of the top ranked candidates are supported by publications reinforcing our confidence in the approach.<\/jats:p>","DOI":"10.1038\/s41598-023-34863-9","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T10:02:15Z","timestamp":1684749735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii"],"prefix":"10.1038","volume":"13","author":[{"given":"Stephen J.","family":"Goodswen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"key":"34863_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s1369-5274(00)00119-3","volume":"3","author":"R Rappuoli","year":"2000","unstructured":"Rappuoli, R. Reverse vaccinology. Curr. Opin. Microbiol. 3, 445\u2013450. https:\/\/doi.org\/10.1016\/s1369-5274(00)00119-3 (2000).","journal-title":"Curr. Opin. Microbiol."},{"key":"34863_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1126\/science.282.5389.682","volume":"282","author":"FS Collins","year":"1998","unstructured":"Collins, F. S. et al. New goals for the US Human Genome Project: 1998\u20132003. Science 282, 682\u2013689. https:\/\/doi.org\/10.1126\/science.282.5389.682 (1998).","journal-title":"Science"},{"key":"34863_CR3","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","volume":"33","author":"A Sette","year":"2010","unstructured":"Sette, A. & Rappuoli, R. Reverse vaccinology: Developing vaccines in the era of genomics. Immunity 33, 530\u2013541. https:\/\/doi.org\/10.1016\/j.immuni.2010.09.017 (2010).","journal-title":"Immunity"},{"key":"34863_CR4","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","volume":"23","author":"FS Nogueira","year":"2005","unstructured":"Nogueira, F. S. et al. Leishmune (R) vaccine blocks the transmission of canine visceral leishmaniasis\u2014Absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine 23, 4805\u20134810. https:\/\/doi.org\/10.1016\/j.vaccine.2005.05.011 (2005).","journal-title":"Vaccine"},{"key":"34863_CR5","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","volume":"23","author":"JL Lemesre","year":"2005","unstructured":"Lemesre, J. L. et al. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23, 2825\u20132840. https:\/\/doi.org\/10.1016\/j.vaccine.2004.11.061 (2005).","journal-title":"Vaccine"},{"key":"34863_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.vetpar.2014.04.025","volume":"204","author":"MC de Souza Testasicca","year":"2014","unstructured":"de Souza Testasicca, M. C. et al. Antibody responses induced by Leish-Tec (R), an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population. Vet. Parasitol. 204, 169\u2013176. https:\/\/doi.org\/10.1016\/j.vetpar.2014.04.025 (2014).","journal-title":"Vet. Parasitol."},{"key":"34863_CR7","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.vaccine.2018.02.111","volume":"36","author":"J Fernandez Cotrina","year":"2018","unstructured":"Fernandez Cotrina, J. et al. A large-scale field randomized trial demonstrates safety and efficacy of the vaccine LetiFend((R)) against canine leishmaniosis. Vaccine 36, 1972\u20131982. https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.111 (2018).","journal-title":"Vaccine"},{"key":"34863_CR8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1365-3024.2010.01209.x","volume":"32","author":"PA Sharman","year":"2010","unstructured":"Sharman, P. A., Smith, N. C., Wallach, M. G. & Katrib, M. Chasing the golden egg: Vaccination against poultry coccidiosis. Parasite Immunol. 32, 590\u2013598. https:\/\/doi.org\/10.1111\/j.1365-3024.2010.01209.x (2010).","journal-title":"Parasite Immunol."},{"key":"34863_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00480169.1988.35461","volume":"36","author":"E Oconnell","year":"1988","unstructured":"Oconnell, E., Wilkins, M. F. & Punga, W. A. T. Toxoplasmosis in sheep. II. The ability of a live vaccine to prevent lamb losses after an intravenous challenge with Toxoplasma gondii. N. Z. Vet. J. 36, 1\u20134. https:\/\/doi.org\/10.1080\/00480169.1988.35461 (1988).","journal-title":"N. Z. Vet. J."},{"key":"34863_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0169-4758(99)01623-3","volume":"16","author":"ME Olson","year":"2000","unstructured":"Olson, M. E., Ceri, H. & Morck, D. W. Giardia vaccination. Parasitol. Today 16, 213\u2013217. https:\/\/doi.org\/10.1016\/s0169-4758(99)01623-3 (2000).","journal-title":"Parasitol. Today"},{"key":"34863_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fawpar.2019.e00053","author":"EA Innes","year":"2019","unstructured":"Innes, E. A., Hamilton, C., Garcia, J. L., Chryssafidis, A. & Smith, D. A one health approach to vaccines against Toxoplasma gondii. Food Waterborne Parasitol. https:\/\/doi.org\/10.1016\/j.fawpar.2019.e00053 (2019).","journal-title":"Food Waterborne Parasitol."},{"key":"34863_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1017\/s0031182013002060","volume":"141","author":"MM McAllister","year":"2014","unstructured":"McAllister, M. M. Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs. Parasitology 141, 624\u2013640. https:\/\/doi.org\/10.1017\/s0031182013002060 (2014).","journal-title":"Parasitology"},{"key":"34863_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00204","author":"CB Palatnik-de-Sousa","year":"2020","unstructured":"Palatnik-de-Sousa, C. B. & Nico, D. The delay in the licensing of protozoal vaccines: A comparative history. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00204 (2020).","journal-title":"Front. Immunol."},{"key":"34863_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","volume":"35","author":"J-L Wang","year":"2019","unstructured":"Wang, J.-L. et al. Advances in the development of anti-Toxoplasma gondii vaccines: Challenges, opportunities, and perspectives. Trends Parasitol. 35, 239\u2013253. https:\/\/doi.org\/10.1016\/j.pt.2019.01.005 (2019).","journal-title":"Trends Parasitol."},{"key":"34863_CR15","doi-asserted-by":"publisher","first-page":"852591","DOI":"10.1155\/2012\/852591","volume":"2012","author":"S Frolich","year":"2012","unstructured":"Frolich, S., Entzeroth, R. & Wallach, M. Comparison of protective immune responses to apicomplexan parasites. J. Parasitol. Res. 2012, 852591\u2013852591. https:\/\/doi.org\/10.1155\/2012\/852591 (2012).","journal-title":"J. Parasitol. Res."},{"key":"34863_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1126\/science.1115252","volume":"309","author":"DS Roos","year":"2005","unstructured":"Roos, D. S. Themes and variations in apicomplexan parasite biology. Science 309, 72\u201373. https:\/\/doi.org\/10.1126\/science.1115252 (2005).","journal-title":"Science"},{"key":"34863_CR17","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/pathogens10111351","volume":"10","author":"D Daher","year":"2021","unstructured":"Daher, D. et al. Comprehensive overview of Toxoplasma gondii-induced and associated diseases. Pathogens 10, 1351. https:\/\/doi.org\/10.3390\/pathogens10111351 (2021).","journal-title":"Pathogens"},{"key":"34863_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.pt.2020.08.005","volume":"36","author":"G Milne","year":"2020","unstructured":"Milne, G., Webster, J. P. & Walker, M. Toxoplasma gondii: An underestimated threat?. Trends Parasitol. 36, 959\u2013969. https:\/\/doi.org\/10.1016\/j.pt.2020.08.005 (2020).","journal-title":"Trends Parasitol."},{"key":"34863_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ijpara.2003.12.009","volume":"34","author":"K Kim","year":"2004","unstructured":"Kim, K. & Weiss, L. M. Toxoplasma gondii: The model apicomplexan. Int. J. Parasitol. 34, 423\u2013432. https:\/\/doi.org\/10.1016\/j.ijpara.2003.12.009 (2004).","journal-title":"Int. J. Parasitol."},{"key":"34863_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-04445-z","author":"M Attias","year":"2020","unstructured":"Attias, M. et al. The life-cycle of Toxoplasma gondii reviewed using animations. Parasites Vectors https:\/\/doi.org\/10.1186\/s13071-020-04445-z (2020).","journal-title":"Parasites Vectors"},{"key":"34863_CR21","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.micinf.2012.09.005","volume":"14","author":"JF Dubremetz","year":"2012","unstructured":"Dubremetz, J. F. & Lebrun, M. Virulence factors of Toxoplasma gondii. Microbes Infect. 14, 1403\u20131410. https:\/\/doi.org\/10.1016\/j.micinf.2012.09.005 (2012).","journal-title":"Microbes Infect."},{"key":"34863_CR22","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1080\/21505594.2021.2012346","volume":"12","author":"SG Sanchez","year":"2021","unstructured":"Sanchez, S. G. & Besteiro, S. The pathogenicity and virulence of Toxoplasma gondii. Virulence 12, 3095\u20133114. https:\/\/doi.org\/10.1080\/21505594.2021.2012346 (2021).","journal-title":"Virulence"},{"key":"34863_CR23","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/s0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter, A. M., Heckeroth, A. R. & Weiss, L. M. Toxoplasma gondii: From animals to humans. Int. J. Parasitol. 30, 1217\u20131258. https:\/\/doi.org\/10.1016\/s0020-7519(00)00124-7 (2000).","journal-title":"Int. J. Parasitol."},{"key":"34863_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050413","author":"K-B Chu","year":"2021","unstructured":"Chu, K.-B. & Quan, F.-S. Advances in Toxoplasma gondii vaccines: Current strategies and challenges for vaccine development. Vaccines https:\/\/doi.org\/10.3390\/vaccines9050413 (2021).","journal-title":"Vaccines"},{"key":"34863_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/14712598.2018.1413086","volume":"18","author":"Y Li","year":"2018","unstructured":"Li, Y. & Zhou, H. Moving towards improved vaccines for Toxoplasma gondii. Expert Opin. Biol. Ther. 18, 273\u2013280. https:\/\/doi.org\/10.1080\/14712598.2018.1413086 (2018).","journal-title":"Expert Opin. Biol. Ther."},{"key":"34863_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-022-02998-9","author":"AJ Mamaghani","year":"2022","unstructured":"Mamaghani, A. J. et al. Toxoplasma gondii vaccine candidates: A concise review. Ir. J. Med. Sci. https:\/\/doi.org\/10.1007\/s11845-022-02998-9 (2022).","journal-title":"Ir. J. Med. Sci."},{"key":"34863_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.micpath.2018.11.003","volume":"126","author":"F Rezaei","year":"2019","unstructured":"Rezaei, F. et al. A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunization. Microb. Pathog. 126, 172\u2013184. https:\/\/doi.org\/10.1016\/j.micpath.2018.11.003 (2019).","journal-title":"Microb. Pathog."},{"key":"34863_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003611","author":"ZQ Chen","year":"2008","unstructured":"Chen, Z. Q., Harb, O. S. & Roos, D. S. In silico identification of specialized secretory-organelle proteins in apicomplexan parasites and in vivo validation in Toxoplasma gondii. Plos One https:\/\/doi.org\/10.1371\/journal.pone.0003611 (2008).","journal-title":"Plos One"},{"key":"34863_CR29","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1016\/j.vaccine.2019.05.083","volume":"37","author":"F-K Loh","year":"2019","unstructured":"Loh, F.-K., Nathan, S., Chow, S.-C. & Fang, C.-M. Vaccination challenges and strategies against long-lived Toxoplasma gondii. Vaccine 37, 3989\u20134000. https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.083 (2019).","journal-title":"Vaccine"},{"key":"34863_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020423","author":"J-X Yang","year":"2022","unstructured":"Yang, J.-X. et al. Recent advances in the development of toll-like receptor agonist-based vaccine adjuvants for infectious diseases. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics14020423 (2022).","journal-title":"Pharmaceutics"},{"key":"34863_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran, B., Arunachalam, P. S. & O\u2019Hagan, D. T. Emerging concepts in the science of vaccine adjuvants. Nat. Rev. Drug Discov. 20, 454\u2013475. https:\/\/doi.org\/10.1038\/s41573-021-00163-y (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"34863_CR32","first-page":"22","volume":"22","author":"J Babaie","year":"2018","unstructured":"Babaie, J. et al. Immunization of C57BL\/6 Mice with GRA2 combined with MPL conferred partial immune protection against Toxoplasma gondii. Iran. Biomed. J. 22, 22\u201332 (2018).","journal-title":"Iran. Biomed. J."},{"key":"34863_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111946","author":"R Bezbaruah","year":"2022","unstructured":"Bezbaruah, R. et al. Nanoparticle-based delivery systems for vaccines. Vaccines https:\/\/doi.org\/10.3390\/vaccines10111946 (2022).","journal-title":"Vaccines"},{"key":"34863_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines\u2014A new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\u2013279. https:\/\/doi.org\/10.1038\/nrd.2017.243 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"34863_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines4020012","author":"A Vartak","year":"2016","unstructured":"Vartak, A. & Sucheck, S. J. Recent advances in subunit vaccine carriers. Vaccines https:\/\/doi.org\/10.3390\/vaccines4020012 (2016).","journal-title":"Vaccines"},{"key":"34863_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.025","volume":"303","author":"N Wang","year":"2019","unstructured":"Wang, N., Chen, M. & Wang, T. Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization. J. Control. Release 303, 130\u2013150. https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.025 (2019).","journal-title":"J. Control. Release"},{"key":"34863_CR37","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2157818","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Insight into the current Toxoplasma gondii DNA vaccine: A review article. Expert Rev. Vaccines https:\/\/doi.org\/10.1080\/14760584.2023.2157818 (2022).","journal-title":"Expert Rev. Vaccines"},{"key":"34863_CR38","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","volume":"19","author":"MO Mohsen","year":"2022","unstructured":"Mohsen, M. O. & Bachmann, M. F. Virus-like particle vaccinology, from bench to bedside. Cell. Mol. Immunol. 19, 993\u20131011. https:\/\/doi.org\/10.1038\/s41423-022-00897-8 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"34863_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3347\/kjp.2019.57.5.543","volume":"57","author":"H-J Kang","year":"2019","unstructured":"Kang, H.-J. et al. Virus-like particle vaccine containing Toxoplasma gondii rhoptry protein 13 induces protection against T. gondii ME49 Infection in Mice. Korean J. Parasitol. 57, 543\u2013547. https:\/\/doi.org\/10.3347\/kjp.2019.57.5.543 (2019).","journal-title":"Korean J. Parasitol."},{"key":"34863_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/cei.13287","volume":"196","author":"J Wallis","year":"2019","unstructured":"Wallis, J., Shenton, D. P. & Carlisle, R. C. Novel approaches for the design, delivery and administration of vaccine technologies. Clin. Exp. Immunol. 196, 189\u2013204. https:\/\/doi.org\/10.1111\/cei.13287 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"34863_CR41","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1586\/14760584.2015.1081067","volume":"14","author":"L Zhang","year":"2015","unstructured":"Zhang, L., Wang, W. & Wang, S. Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev. Vaccines 14, 1509\u20131523. https:\/\/doi.org\/10.1586\/14760584.2015.1081067 (2015).","journal-title":"Expert Rev. Vaccines"},{"key":"34863_CR42","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","volume":"172","author":"DK Howe","year":"1995","unstructured":"Howe, D. K. & Sibley, L. D. Toxoplasma gondii comprises three clonal lineages: Correlation of parasite genotype with human disease. J. Infect. Dis. 172, 1561\u20131566. https:\/\/doi.org\/10.1093\/infdis\/172.6.1561 (1995).","journal-title":"J. Infect. Dis."},{"key":"34863_CR43","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/bioinformatics\/btl158","volume":"22","author":"W Li","year":"2006","unstructured":"Li, W. & Godzik, A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22, 1658\u20131659. https:\/\/doi.org\/10.1093\/bioinformatics\/btl158 (2006).","journal-title":"Bioinformatics"},{"key":"34863_CR44","doi-asserted-by":"publisher","DOI":"10.1101\/gr.262816.120","author":"J Xia","year":"2021","unstructured":"Xia, J. et al. Third-generation sequencing revises the molecular karyotype for Toxoplasma gondii and identifies emerging copy number variants in sexual recombinants. Genome Res. https:\/\/doi.org\/10.1101\/gr.262816.120 (2021).","journal-title":"Genome Res."},{"issue":"Suppl 2","key":"34863_CR45","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1745-7580-6-s2-s3","volume":"6","author":"C Lundegaard","year":"2010","unstructured":"Lundegaard, C., Hoof, I., Lund, O. & Nielsen, M. State of the art and challenges in sequence based T-cell epitope prediction. Immunome Res. 6(Suppl 2), S3\u2013S3. https:\/\/doi.org\/10.1186\/1745-7580-6-s2-s3 (2010).","journal-title":"Immunome Res."},{"key":"34863_CR46","doi-asserted-by":"publisher","first-page":"8739","DOI":"10.1073\/pnas.0401283101","volume":"101","author":"C Rollenhagen","year":"2004","unstructured":"Rollenhagen, C., Sorensen, M., Rizos, K., Hurvitz, R. & Bumann, D. Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen. Proc. Natl. Acad. Sci. U. S. A. 101, 8739\u20138744. https:\/\/doi.org\/10.1073\/pnas.0401283101 (2004).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"34863_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4161\/hv.7.0.14556","volume":"7","author":"J Schroeder","year":"2011","unstructured":"Schroeder, J. & Aebischer, T. Vaccines for leishmaniasis from proteome to vaccine candidates. Hum. Vaccin. 7, 10\u201315. https:\/\/doi.org\/10.4161\/hv.7.0.14556 (2011).","journal-title":"Hum. Vaccin."},{"key":"34863_CR48","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ni.1728","volume":"10","author":"S Tenzer","year":"2009","unstructured":"Tenzer, S. et al. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. Nat. Immunol. 10, 636-U109. https:\/\/doi.org\/10.1038\/ni.1728 (2009).","journal-title":"Nat. Immunol."},{"key":"34863_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel, C. & Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227\u2013232. https:\/\/doi.org\/10.1038\/nrg3185 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"34863_CR50","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.1093\/nar\/gkx898","volume":"45","author":"JJ Li","year":"2017","unstructured":"Li, J. J., Chew, G.-L. & Biggin, M. D. Quantitating translational control: mRNA abundance-dependent and independent contributions and the mRNA sequences that specify them. Nucleic Acids Res. 45, 11821\u201311836. https:\/\/doi.org\/10.1093\/nar\/gkx898 (2017).","journal-title":"Nucleic Acids Res."},{"key":"34863_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-018-2983-5","author":"L-F Chen","year":"2018","unstructured":"Chen, L.-F. et al. Comparative studies of Toxoplasma gondii transcriptomes: Insights into stage conversion based on gene expression profiling and alternative splicing. Parasites Vectors https:\/\/doi.org\/10.1186\/s13071-018-2983-5 (2018).","journal-title":"Parasites Vectors"},{"key":"34863_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-019-6213-0","author":"AL Garfoot","year":"2019","unstructured":"Garfoot, A. L., Wilson, G. M., Coon, J. J. & Knoll, L. J. Proteomic and transcriptomic analyses of early and late-chronic Toxoplasma gondii infection shows novel and stage specific transcripts. BMC Genom. https:\/\/doi.org\/10.1186\/s12864-019-6213-0 (2019).","journal-title":"BMC Genom."},{"key":"34863_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173018","author":"PS Guiton","year":"2017","unstructured":"Guiton, P. S., Sagawa, J. M., Fritz, H. M. & Boothroyd, J. C. An in vitro model of intestinal infection reveals a developmentally regulated transcriptome of Toxoplasma sporozoites and a NF-kappa B-like signature in infected host cells. Plos One https:\/\/doi.org\/10.1371\/journal.pone.0173018 (2017).","journal-title":"Plos One"},{"key":"34863_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-017-4362-6","author":"MA Hassan","year":"2017","unstructured":"Hassan, M. A., Vasquez, J. J., Guo-Liang, C., Meissner, M. & Siegel, T. N. Comparative ribosome profiling uncovers a dominant role for translational control in Toxoplasma gondii. BMC Genom. https:\/\/doi.org\/10.1186\/s12864-017-4362-6 (2017).","journal-title":"BMC Genom."},{"key":"34863_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-806","author":"KJ Pittman","year":"2014","unstructured":"Pittman, K. J., Aliota, M. T. & Knoll, L. J. Dual transcriptional profiling of mice and Toxoplasma gondii during acute and chronic infection. BMC Genom. https:\/\/doi.org\/10.1186\/1471-2164-15-806 (2014).","journal-title":"BMC Genom."},{"key":"34863_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002567","author":"AJ Reid","year":"2012","unstructured":"Reid, A. J. et al. Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum: Coccidia differing in host range and transmission strategy. Plos Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1002567 (2012).","journal-title":"Plos Pathog."},{"key":"34863_CR57","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.micinf.2020.09.001","volume":"22","author":"J Sharma","year":"2020","unstructured":"Sharma, J., Rodriguez, P., Roy, P. & Guiton, P. S. Transcriptional ups and downs: Patterns of gene expression in the life cycle of Toxoplasma gondii. Microbes Infect. 22, 525\u2013533. https:\/\/doi.org\/10.1016\/j.micinf.2020.09.001 (2020).","journal-title":"Microbes Infect."},{"key":"34863_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cell.2019.12.013","volume":"180","author":"BS Waldman","year":"2020","unstructured":"Waldman, B. S. et al. Identification of a master regulator of differentiation in toxoplasma. Cell 180, 359. https:\/\/doi.org\/10.1016\/j.cell.2019.12.013 (2020).","journal-title":"Cell"},{"key":"34863_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-568","author":"P Wang","year":"2010","unstructured":"Wang, P. et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinform. https:\/\/doi.org\/10.1186\/1471-2105-11-568 (2010).","journal-title":"BMC Bioinform."},{"key":"34863_CR60","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/imm.12889","volume":"154","author":"KK Jensen","year":"2018","unstructured":"Jensen, K. K. et al. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology 154, 394\u2013406. https:\/\/doi.org\/10.1111\/imm.12889 (2018).","journal-title":"Immunology"},{"key":"34863_CR61","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","volume":"19","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B. et al. Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data. J. Proteome Res. 19, 2304\u20132315. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00874 (2020).","journal-title":"J. Proteome Res."},{"key":"34863_CR62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/prot.21078","volume":"65","author":"S Saha","year":"2006","unstructured":"Saha, S. & Raghava, G. P. S. Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins-Struct. Funct. Bioinform. 65, 40\u201348. https:\/\/doi.org\/10.1002\/prot.21078 (2006).","journal-title":"Proteins-Struct. Funct. Bioinform."},{"key":"34863_CR63","unstructured":"Saha, S. & Raghava, G. P. S. in Artificial Immune Systems, Proceedings Vol. 3239 Lecture Notes in Computer Science (eds G. Nicosia, V. Cutello, P. J. Bentley, & J. Timmis) 197\u2013204 (2004)."},{"key":"34863_CR64","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen, M. C., Peters, B., Nielsen, M. & Marcatili, P. BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 45, W24\u2013W29. https:\/\/doi.org\/10.1093\/nar\/gkx346 (2017).","journal-title":"Nucleic Acids Res."},{"key":"34863_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4497","author":"JN Clifford","year":"2022","unstructured":"Clifford, J. N. et al. BepiPred-3.0: Improved B-cell epitope prediction using protein language models. Protein Sci. https:\/\/doi.org\/10.1002\/pro.4497 (2022).","journal-title":"Protein Sci."},{"key":"34863_CR66","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1093\/bioinformatics\/btu300","volume":"30","author":"SJ Goodswen","year":"2014","unstructured":"Goodswen, S. J., Kennedy, P. J. & Ellis, J. T. Vacceed: A high-throughput in silico vaccine candidate discovery pipeline for eukaryotic pathogens based on reverse vaccinology. Bioinformatics 30, 2381\u20132383. https:\/\/doi.org\/10.1093\/bioinformatics\/btu300 (2014).","journal-title":"Bioinformatics"},{"key":"34863_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002829","author":"JV Kringelum","year":"2012","unstructured":"Kringelum, J. V., Lundegaard, C., Lund, O. & Nielsen, M. Reliable B cell epitope predictions: Impacts of method development and improved benchmarking. Plos Comput. Biol. https:\/\/doi.org\/10.1371\/journal.pcbi.1002829 (2012).","journal-title":"Plos Comput. Biol."},{"key":"34863_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-514","author":"J Ponomarenko","year":"2008","unstructured":"Ponomarenko, J. et al. ElliPro: A new structure-based tool for the prediction of antibody epitopes. BMC Bioinform. https:\/\/doi.org\/10.1186\/1471-2105-9-514 (2008).","journal-title":"BMC Bioinform."},{"key":"34863_CR69","doi-asserted-by":"publisher","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","volume":"50","author":"M Varadi","year":"2022","unstructured":"Varadi, M. et al. AlphaFold protein structure database: Massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439\u2013D444. https:\/\/doi.org\/10.1093\/nar\/gkab1061 (2022).","journal-title":"Nucleic Acids Res."},{"key":"34863_CR70","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583. https:\/\/doi.org\/10.1038\/s41586-021-03819-2 (2021).","journal-title":"Nature"},{"key":"34863_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00332","author":"SJ Goodswen","year":"2018","unstructured":"Goodswen, S. J., Kennedy, P. J. & Ellis, J. T. A gene-based positive selection detection approach to identify vaccine candidates using Toxoplasma gondii as a test case protozoan pathogen. Front. Genet. https:\/\/doi.org\/10.3389\/fgene.2018.00332 (2018).","journal-title":"Front. Genet."},{"key":"34863_CR72","doi-asserted-by":"publisher","first-page":"105499","DOI":"10.1016\/j.actatropica.2020.105499","volume":"208","author":"SH Fernandez Villamil","year":"2020","unstructured":"Fernandez Villamil, S. H. & Vilchez Larrea, S. C. Poly(ADP-ribose) metabolism in human parasitic protozoa. Acta Tropica 208, 105499. https:\/\/doi.org\/10.1016\/j.actatropica.2020.105499 (2020).","journal-title":"Acta Tropica"},{"key":"34863_CR73","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4049\/jimmunol.166.1.498","volume":"166","author":"P Probst","year":"2001","unstructured":"Probst, P. et al. Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J. Immunol. 166, 498\u2013505. https:\/\/doi.org\/10.4049\/jimmunol.166.1.498 (2001).","journal-title":"J. Immunol."},{"key":"34863_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040357","author":"Z Yu","year":"2021","unstructured":"Yu, Z. et al. Recombinant Toxoplasma gondii ribosomal protein P2 modulates the functions of murine macrophages in vitro and provides immunity against acute toxoplasmosis in vivo. Vaccines https:\/\/doi.org\/10.3390\/vaccines9040357 (2021).","journal-title":"Vaccines"},{"key":"34863_CR75","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1126\/science.1074553","volume":"298","author":"M Meissner","year":"2002","unstructured":"Meissner, M., Schluter, D. & Soldati, D. Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion. Science 298, 837\u2013840. https:\/\/doi.org\/10.1126\/science.1074553 (2002).","journal-title":"Science"},{"key":"34863_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164991","author":"J Gupta","year":"2016","unstructured":"Gupta, J., Misra, S. & Misra-Bhattacharya, S. Immunization with Brugia malayi myosin as heterologous DNA prime protein boost induces protective immunity against B-malayi infection in Mastomys coucha. Plos One https:\/\/doi.org\/10.1371\/journal.pone.0164991 (2016).","journal-title":"Plos One"},{"key":"34863_CR77","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00793-21","author":"WJ Moss","year":"2022","unstructured":"Moss, W. J., Patterson, C. E., Jochmans, A. K. & Brown, K. M. Functional analysis of the expanded phosphodiesterase gene family in Toxoplasma gondii tachyzoites. Msphere https:\/\/doi.org\/10.1128\/msphere.00793-21 (2022).","journal-title":"Msphere"},{"key":"34863_CR78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.molbiopara.2009.02.006","volume":"166","author":"HK Rofatto","year":"2009","unstructured":"Rofatto, H. K. et al. Characterization of phosphodiesterase-5 as a surface protein in the tegument of Schistosoma mansoni. Mol. Biochem. Parasitol. 166, 32\u201341. https:\/\/doi.org\/10.1016\/j.molbiopara.2009.02.006 (2009).","journal-title":"Mol. Biochem. Parasitol."},{"key":"34863_CR79","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/pim.12024","volume":"35","author":"P Gong","year":"2013","unstructured":"Gong, P. et al. The protective effect of a DNA vaccine encoding the Toxoplasma gondii cyclophilin gene in BALB\/c mice. Parasite Immunol. 35, 140\u2013146. https:\/\/doi.org\/10.1111\/pim.12024 (2013).","journal-title":"Parasite Immunol."},{"key":"34863_CR80","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1016\/j.vaccine.2021.06.032","volume":"39","author":"W Tuo","year":"2021","unstructured":"Tuo, W. et al. Vaccination with Neospora caninum-cyclophilin and -profilin confers partial protection against experimental neosporosis-induced abortion in sheep. Vaccine 39, 4534\u20134544. https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.032 (2021).","journal-title":"Vaccine"},{"key":"34863_CR81","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/bioinformatics\/btw015","volume":"32","author":"M-A Dragan","year":"2016","unstructured":"Dragan, M.-A., Moghul, I., Priyam, A., Bustos, C. & Wurm, Y. GeneValidator: Identify problems with protein-coding gene predictions. Bioinformatics 32, 1559\u20131561. https:\/\/doi.org\/10.1093\/bioinformatics\/btw015 (2016).","journal-title":"Bioinformatics"},{"key":"34863_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1715-2","author":"SL Salzberg","year":"2019","unstructured":"Salzberg, S. L. Next-generation genome annotation: We still struggle to get it right. Genome Biol. https:\/\/doi.org\/10.1186\/s13059-019-1715-2 (2019).","journal-title":"Genome Biol."},{"key":"34863_CR83","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.meegid.2012.08.012","volume":"13","author":"SJ Goodswen","year":"2013","unstructured":"Goodswen, S. J., Kennedy, P. J. & Ellis, J. T. A review of the infection, genetics, and evolution of Neospora caninum: From the past to the present. Infect. Genet. Evol. 13, 133\u2013150. https:\/\/doi.org\/10.1016\/j.meegid.2012.08.012 (2013).","journal-title":"Infect. Genet. Evol."},{"key":"34863_CR84","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3347\/kjp.2008.46.4.209","volume":"46","author":"JY Kim","year":"2008","unstructured":"Kim, J. Y., Ahn, H.-J., Ryu, K. J. & Nam, H.-W. Interaction between parasitophorous vacuolar membrane-associated GRA3 and calcium modulating ligand of host cell endoplasmic reticulum in the parasitism of Toxoplasma gondii. Korean J. Parasitol. 46, 209\u2013216. https:\/\/doi.org\/10.3347\/kjp.2008.46.4.209 (2008).","journal-title":"Korean J. Parasitol."},{"key":"34863_CR85","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1128\/ec.00150-09","volume":"8","author":"A Khan","year":"2009","unstructured":"Khan, A., Behnke, M. S., Dunay, I. R., White, M. W. & Sibley, L. D. Phenotypic and gene expression changes among clonal type I strains of Toxoplasma gondii. Eukaryot. Cell 8, 1828\u20131836. https:\/\/doi.org\/10.1128\/ec.00150-09 (2009).","journal-title":"Eukaryot. Cell"},{"key":"34863_CR86","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1128\/cdli.8.4.811-817.2001","volume":"8","author":"Y Nishikawa","year":"2001","unstructured":"Nishikawa, Y. et al. In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages. Clin. Diagn. Lab. Immunol. 8, 811\u2013817. https:\/\/doi.org\/10.1128\/cdli.8.4.811-817.2001 (2001).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"34863_CR87","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1091\/mbc.E07-07-0650","volume":"19","author":"IM Olazabal","year":"2008","unstructured":"Olazabal, I. M. et al. Activation outcomes induced in naive CD8 T-cells by macrophages primed via \u201cPhagocytic\u201d and nonphagocytic pathways. Mol. Biol. Cell 19, 701\u2013710. https:\/\/doi.org\/10.1091\/mbc.E07-07-0650 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"34863_CR88","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1021\/pr200621z","volume":"10","author":"ML Biniossek","year":"2011","unstructured":"Biniossek, M. L., Naegler, D. K., Becker-Pauly, C. & Schilling, O. Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S. J. Proteome Res. 10, 5363\u20135373. https:\/\/doi.org\/10.1021\/pr200621z (2011).","journal-title":"J. Proteome Res."},{"key":"34863_CR89","doi-asserted-by":"publisher","first-page":"D898","DOI":"10.1093\/nar\/gkab929","volume":"50","author":"B Amos","year":"2022","unstructured":"Amos, B. et al. VEuPathDB: The eukaryotic pathogen, vector and host bioinformatics resource center. Nucleic Acids Res. 50, D898\u2013D911. https:\/\/doi.org\/10.1093\/nar\/gkab929 (2022).","journal-title":"Nucleic Acids Res."},{"key":"34863_CR90","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1032","author":"EW Sayers","year":"2022","unstructured":"Sayers, E. W. et al. Database resources of the national center for biotechnology information in 2023. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkac1032 (2022).","journal-title":"Nucleic Acids Res."},{"key":"34863_CR91","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac174","author":"N Sharma","year":"2022","unstructured":"Sharma, N., Naorem, L. D., Jain, S. & Raghava, G. P. S. ToxinPred2: An improved method for predicting toxicity of proteins. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbac174 (2022).","journal-title":"Brief. Bioinform."},{"key":"34863_CR92","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0097-8485(93)85006-x","volume":"17","author":"JC Wootton","year":"1993","unstructured":"Wootton, J. C. & Federhen, S. Statistics of local complexity in amino acid sequences and sequence databases. Comput. Chem. 17, 149\u2013163. https:\/\/doi.org\/10.1016\/0097-8485(93)85006-x (1993).","journal-title":"Comput. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34863-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34863-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34863-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T10:24:50Z","timestamp":1684751090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34863-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34863"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34863-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8243"}}